Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ligand Pharmaceuticals

108.07
-0.4800-0.44%
Post-market: 108.070.00000.00%19:41 EDT
Volume:102.96K
Turnover:11.00M
Market Cap:2.08B
PE:-490.23
High:108.34
Open:106.95
Low:104.65
Close:108.55
Loading ...

Oppenheimer Adjusts Ligand Pharmaceuticals Price Target to $147 From $135, Maintains Outperform Rating

MT Newswires Live
·
09 Nov 2024

Ligand Pharmaceuticals Inc : Barclays Raises Target Price to $150 From $125

THOMSON REUTERS
·
08 Nov 2024

Ligand price target raised to $150 from $125 at Barclays

TIPRANKS
·
08 Nov 2024

Ligand Pharmaceuticals Price Target Maintained With a $157.00/Share by HC Wainwright & Co.

Dow Jones
·
08 Nov 2024

Ligand Pharmaceuticals Inc (LGND) Q3 2024 Earnings Call Highlights: Record Revenue Growth and ...

GuruFocus.com
·
08 Nov 2024

Ligand Pharmaceuticals Reports Strong Q3 2024 Growth

TIPRANKS
·
08 Nov 2024

Ligand Shares Rise After Q3 Tops Expectations, Guidance Raised

MT Newswires Live
·
08 Nov 2024

Stock Track | Ligand Pharmaceuticals Soars 5% on Stellar Q3 Results and Raised Guidance

Stock Track
·
07 Nov 2024

Ligand Pharmaceuticals Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
07 Nov 2024

Ligand: Q3 Earnings Snapshot

Associated Press Finance
·
07 Nov 2024

BRIEF-Ligand Reports Q3 2024 Financial Results And Raises 2024 Guidance

Reuters
·
07 Nov 2024

Ligand Pharmaceuticals Q3 2024 Adj. EPS $1.84 Beats $1.35 Estimate, Sales $51.812M Beat $40.650M Estimate

Benzinga
·
07 Nov 2024

Ligand Pharmaceuticals Inc Outlook 2024 Core Adjusted Earnings per Diluted Share $5.50 - $5.70

THOMSON REUTERS
·
07 Nov 2024

Ligand Pharmaceuticals Inc: 2024 Full Year Revenue Guidance Increased to $160 Mln - $165 Mln

THOMSON REUTERS
·
07 Nov 2024

Ligand Reports Third Quarter 2024 Financial Results and Raises 2024 Guidance

Business Wire
·
07 Nov 2024

Ligand to Host Investor and Analyst Day on December 10, 2024 in Boston

Business Wire
·
01 Nov 2024

Market Participants Recognise Ligand Pharmaceuticals Incorporated's (NASDAQ:LGND) Earnings

Simply Wall St.
·
01 Nov 2024

Ligand Pharmaceuticals Price Target Maintained With a $157.00/Share by HC Wainwright & Co.

Dow Jones
·
31 Oct 2024

Ligand Pharmaceuticals Is Maintained at Overweight by Barclays

Dow Jones
·
28 Oct 2024